Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease

INTRODUCTION: Chronic obstructive pulmonary disease (COPD), characterized by a progressive deterioration of lung function caused primarily by the inhalation of toxic substances, is a leading cause of morbidity and mortality worldwide. Current treatment options for the management of its symptoms incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Linda Timm, Kenreigh, Charlotte A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2005
Materias:
Proof of Concept Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321655/
https://www.ncbi.nlm.nih.gov/pubmed/22496674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3321655/
https://www.ncbi.nlm.nih.gov/pubmed/22496674

Ejemplares similares